You are here

BetterLife Pharma Inc.

BetterLife Pharma  Inc.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
BETR
CSE Index: 
Currency: 

BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders.

BETR-001, which is in preclinical and IND-enabling studies, is a non-hallucinogenic and non-controlled LSD derivative in development and it is unique in that it is unregulated and therefore can be self-administered. BetterLife’s synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent for composition and method of use covers treatment of depression, cluster headaches, post-traumatic stress disorder and other neuro-psychiatric and neurological disorders.

BETR-002, which is in preclinical and IND-enabling studies, is based on honokiol, the active anxiolytic ingredient of magnolia bark. BetterLife’s pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency.

BetterLife also owns a drug candidate for the treatment of viral infections such as COVID-19 and is in the process of seeking strategic alternatives for further development.

You are here

BetterLife Pharma Inc. (BETR)

SEDAR Information

Company Info

Address
300 - 1275 West 6th Avenue
Vancouver, BC V6H 1A6
Canada
Fax
604-738-7134
Email
info@blifepharma.com
Website
https://abetterlifepharma.com/
Listing date
Tuesday, December 19, 2017
Transfer Agent
Endeavor Trust Corporation
Investor Relations
David Melles
Email
IR@blifepharma.com
Auditor
MNP LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
88,610,543
Reserved for Issuance: 
12,834,385

Bulletins

31/08/2020

2020-0836 – Fundamental Change - BetterLife Pharma Inc. (BETR)

Le 31 aout/August 2020

Following a fundamental change review the common shares of BetterLife Pharma Inc. have requalified for listing.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2022-12-07-Arcview-Access-Cannabis-Investment-Summit_Website.jpg

Arcview Access Cannabis Investment Summit

Wednesday, December 7, 2022 - 7:00pm to Friday, December 9, 2022 - 1:00pm